Editorial Comment: Tailored Therapies in Patients With HER2-Positive Breast Cancer Could Be Achieved by Using Tumor-Infiltrating Lymphocyte Predictors, Significantly Improving Patient Outcomes.
| Autor: | Papalouka V; Cambridge University Hospital, NHS Foundation Trust, Cambridge, UK vasiliki_papa@hotmail.com. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | AJR. American journal of roentgenology [AJR Am J Roentgenol] 2022 Feb; Vol. 218 (2), pp. 269. Date of Electronic Publication: 2021 Sep 08. |
| DOI: | 10.2214/AJR.21.26749 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|